- Home
- MS vs ABT Comparison
MS vs ABT Comparison
Compare MS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MS
- ABT
- Stock Information
- Founded
- MS 1924
- ABT 1888
- Country
- MS United States
- ABT United States
- Employees
- MS N/A
- ABT N/A
- Industry
- MS Investment Bankers/Brokers/Service
- ABT Medical/Dental Instruments
- Sector
- MS Finance
- ABT Health Care
- Exchange
- MS Nasdaq
- ABT Nasdaq
- Market Cap
- MS 209.6B
- ABT 237.4B
- IPO Year
- MS N/A
- ABT N/A
- Fundamental
- Price
- MS $143.01
- ABT $126.65
- Analyst Decision
- MS Buy
- ABT Strong Buy
- Analyst Count
- MS 13
- ABT 19
- Target Price
- MS $138.25
- ABT $142.79
- AVG Volume (30 Days)
- MS 6.0M
- ABT 7.8M
- Earning Date
- MS 07-16-2025
- ABT 07-17-2025
- Dividend Yield
- MS 2.80%
- ABT 1.86%
- EPS Growth
- MS 45.57
- ABT 151.46
- EPS
- MS 8.83
- ABT 7.97
- Revenue
- MS $65,612,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- MS $9.92
- ABT $7.56
- Revenue Next Year
- MS $4.63
- ABT $7.73
- P/E Ratio
- MS $16.20
- ABT $15.87
- Revenue Growth
- MS 16.92
- ABT 5.85
- 52 Week Low
- MS $90.94
- ABT $99.92
- 52 Week High
- MS $145.16
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- MS 63.12
- ABT 40.94
- Support Level
- MS $138.93
- ABT $123.25
- Resistance Level
- MS $143.72
- ABT $127.04
- Average True Range (ATR)
- MS 2.27
- ABT 2.73
- MACD
- MS -0.44
- ABT -0.53
- Stochastic Oscillator
- MS 88.07
- ABT 45.03
About MS Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 24% of its total revenue is from outside the Americas. The company had over $6 trillion of client assets as well as around 70,000 employees at the end of 2024.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.